Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis.
about
Brincidofovir Use after Foscarnet Crystal Nephropathy in a Kidney Transplant Recipient with Multiresistant Cytomegalovirus Infection.Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infectionNovel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected In Vitro That Confer Brincidofovir Resistance.
P2860
Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Analysis of Mutations in the G ...... of Brincidofovir Prophylaxis.
@en
Analysis of Mutations in the G ...... of Brincidofovir Prophylaxis.
@nl
type
label
Analysis of Mutations in the G ...... of Brincidofovir Prophylaxis.
@en
Analysis of Mutations in the G ...... of Brincidofovir Prophylaxis.
@nl
prefLabel
Analysis of Mutations in the G ...... of Brincidofovir Prophylaxis.
@en
Analysis of Mutations in the G ...... of Brincidofovir Prophylaxis.
@nl
P2093
P2860
P356
P1476
Analysis of Mutations in the G ...... l of Brincidofovir Prophylaxis
@en
P2093
Chad Wilson
Donella Colville
E Randall Lanier
Herve Mommeja-Marin
Scott Foster
Steven Kleiboeker
Sunwen Chou
Tom Brundage
P2860
P356
10.1093/INFDIS/JIW073
P407
P577
2016-03-03T00:00:00Z